INVO Fertility, Inc. filed an 8-K to furnish an investor presentation for the H.C. Wainwright 28th Annual Global Investment Conference scheduled for September 14-16, 2026. The filing also updates progress on a capital raise under an Any Market Purchase Agreement with Alumni Capital LP. Since the registration statement became effective, the company has sold 2,094,395 shares of common stock to the investor for approximately $3,591,000 at an average price of $1.71 per share. The agreement provides a commitment amount of up to $15 million, potentially expandable to $50 million. INVO Fertility, Inc. operates in the fertility healthcare industry, providing assisted reproductive technology services and related products.

INVO Fertility, Inc. entered into an Any Market Purchase Agreement with Alumni Capital LP on July 24, 2026, granting the company the option to sell up to $15 million in common stock, with a potential increase to $50 million. The company also filed a Certificate of Amendment to its Articles of Incorporation to increase authorized shares from 50,000,000 to 250,000,000. INVO Fertility, Inc. is a healthcare company focused on on fertility clinic acquisition and expansion.

INVO Fertility, Inc. completed the acquisition of 100% of the membership interests of HRCFG, LLC through its subsidiary, INVO Centers, LLC, for a total purchase price of $175,001. The transaction involves a $1.00 cash payment at closing, $48,000 in monthly installments over nine months starting in October 2026, and $127,000 to be paid from HRCFG's free cash flow. Additionally, the company's non-compliance with Nasdaq's Timely Filing Rule due to delayed 10-K and 10-Q filings was resolved after the company filed its 10-Q on June 22, 2026. INVO Fertility, Inc. operates in the fertility clinic industry and provides reproductive health services.

INVO Fertility, Inc. issued a press release on June 22, 2026, announcing its financial results for the quarter ended March 31, 2026. The company operates in the fertility services industry and provides medical technology and services related to reproductive health.